Dr Mark Egerton

Mark Egerton

Principal and Head of Life Sciences Team

P: +61 7 3011 2200 | E: megerton@fak.com.au | Fisher Adams Kelly Callinans LinkedIn

Level 6, 175 Eagle St, Brisbane, QLD 4000

“Many of my clients are seeking ways to improve the quality of life for people around the globe. I’m proud to help them pursue that goal, by protecting their innovations within the full extent of the law.”

Mark has more than 20 years patent experience specialising in cell and molecular biology, protein chemistry, immunology, biochemistry, genomics and medical devices.

Mark’s previous scientific experience includes working as a Post-Doctoral Research Scientist in the fields of immunology and signal transduction at the National Institutes of Health (USA) and at the Queensland Institute of Medical Research. Mark’s expertise and experience are highly prized by domestic and international businesses, universities and research institutes that are engaged in developing biotechnology inventions. Mark joined Fisher Adams Kelly in 1997 and became a partner in 2001. Mark frequently contributes to public debates particularly around patent protection issues that arise in the biotechnology industry.

Role & Accountabilities

Mark is committed to working with clients such as universities and startup companies to protect early stage inventions in Australia and major foreign jurisdictions such as Europe, USA, Japan and China. Mark brings a sound understanding of patent strategy to his role, particularly with regard to the complexities of patenting biotechnological inventions, where there are significant differences in law practise between different jurisdictions.

Qualifications & Memberships

  • PhD, The Walter and Eliza Hall Institute, University of Melbourne
  • Bachelor of Science (Hons), The Walter and Eliza Hall Institute, University of Melbourne
  • Registered Patent and Trade Marks Attorney, Australia and New Zealand

Professional Associations

  • Fellow of the Institute of Patent and Trade Marks Attorneys of Australia
  • Australian Biotechnology Association

Authored Content